North America Medical Carts Market is Likely to Witness Steady Growth by 2027

The non-powered (mechanical) energy source segment dominated the North America medical carts market in terms of revenue in 2017 and is likely to maintain its dominance during the forecast period. The Non-powered (mechanical) segment is also the most appealing, with an attractiveness score of 1.2 for the forecast period. This sector is predicted to keep slightly more than 68% of the revenue share of the North America medical carts market in 2017; however, market share is expected to decrease by 432 basis points by 2027. Throughout the projected period, the non-powered (mechanical) sector is expected to develop at a CAGR of 10.4% and be valued slightly more than US$ 1,100 million by the end of 2027.

The increased emphasis on point-of-care diagnosis and treatment has resulted in an increase in the use of mobile computer medical carts. Computer medical carts are used to record and update electronic health records for patients (EHR). Increasing adoption of Electronic Health Records (EHR) is also seen as a driving element in the expansion of the North American medical carts industry.

The integration of information technology (IT) solutions in healthcare settings has been forced by the need to streamline operations. Companies' medical carts are currently performing the critical purpose of assisting nursing operations in medical facilities. The robust healthcare infrastructure in the United States will necessitate the use of innovative medical carts that not only dispens medical devices and supplies, but also have integrated IT systems. In the coming years, the demand for medical carts in North America will show a consistent preference for IT-integrated medical carts.

Key Players Included in the North America’s Medical Carts Market:

Omnicell, Inc., Herman Miller, Inc., The Harloff Company, Capsa Solutions LLC, Medline Industries, Inc., Armstrong Medical Industries, Inc., AFC Industries, Waterloo Healthcare, TouchPoint Medical, and Ergotron, Inc.

Get More Details About Report@ https://www.futuremarketinsights.com/reports/north-america-medical-carts-market

Key Segments:

By End User:

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centres
  • Diagnostic Centres
  • Others

By Material Type:

  • Metal
  • Plastic
  • Wood

By Energy Source:

  • Powered
  • Non-Powered (Mechanical)

By Product Type:

  • Emergency Carts
  • Procedure/Treatment Carts
  • Anaesthesia Carts
  • Medical Computer Carts
  • Others

Comments

Post a Comment

Popular posts from this blog

Handheld Ultrasound Scanners Market Will Generate Booming Growth Opportunities to 2032

Image
According to industry predictions, the global Handheld Ultrasound Scanners Market Demand will increase at a CAGR of 9.1% from 2022 to 2032, reaching a value of US$ 472.1 million by the end of 2022. By 2032, sales are estimated to exceed a valuation of roughly US$ 1.1 billion. With an expected 83.6% market share in 2021, the wired modality now leads the sector. Because they connect to Bluetooth or Wi-Fi devices such as mobile phones or tablets, Handheld Ultrasound Scanners are gaining appeal among both medical professionals and non-radiologists. These devices improve networking systems and ease picture transfer to medical facilities. Global Handheld Ultrasound Scanners Market: Dynamics         Technological advancements in medical imaging devices, increased use of Handheld Ultrasound Scanners among non-radiologists, benefits from international trade agreements, increased importing of imaging diagnostics systems, increased use of Handheld Ultrasound Scanners in emergency medical service
Read more

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

Antidiabetics Market to reach US$ 223 billion by 2032, growing at a 9.6% CAGR from 2022 to 2032 | Future Market Insights, Inc.

Image
The global Antidiabetics Market is expected to earn US$ 223 billion while expanding at a CAGR of 9.6% during the forecast period. The rising prevalence of diabetes worldwide can be attributed to the market's expansion. The ageing baby boomer population is another factor driving the market during the forecast period. According to the International Diabetes Federation, the global diabetes incidence will increase from 366 million in 2011 to 552 million by 2030. During the forecast period, the industry is expected to benefit from a significant increase in the number of diabetic patients. Furthermore, new product development is expected to benefit the market in the near future. For example, Novo Nordisk, a Danish pharmaceutical company, announced the launch of oral semaglutide for the treatment of Type 2 diabetes in India in January 2022. Furthermore, the development of advanced pumps based on smart technologies like AI and ML is expected to open up a slew of new doors. For exampl
Read more